Investigating the role of Cystatin C in multiple sclerosis.

研究半胱氨酸蛋白酶抑制剂 C 在多发性硬化症中的作用。

• 批准号: 303442
• 负责人: Ousman Shalina S
• 金额: $ 66.29万
• 依托单位: Hotchkiss Brain Institute (University of Calgary)
• 依托单位国家: 加拿大
• 项目类别: Operating Grants
• 财政年份: 2014
• 资助国家: 加拿大
• 起止时间: 2014-03-01 至 2019-03-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=303442&lang=en
• 关键词: Cystatin C; Experimental Allergic Encephalomyelitis; Gender Dimorphism; Multiple Sclerosis; Neuroimmunology

Scores of genes and proteins are increased in the brains of multiple sclerosis (MS) patients but the function of most of these molecules is poorly understood. These factors may contribute to development of the disease, progression of disability or attempt

多发性硬化症（MS）患者的大脑中基因和蛋白质的数量增加，但大多数这些分子的功能知之甚少。这些因素可能会导致疾病的发展，残疾的进展或尝试